Perioperative Buprenorphine Management: A Multidisciplinary Approach.
Acetaminophen
/ administration & dosage
Aged
Analgesics, Non-Narcotic
/ administration & dosage
Analgesics, Opioid
/ administration & dosage
Anti-Inflammatory Agents, Non-Steroidal
/ administration & dosage
Arthroplasty, Replacement, Hip
/ adverse effects
Buprenorphine
/ administration & dosage
Combined Modality Therapy
/ methods
Drug Compounding
/ methods
Female
Humans
Interdisciplinary Communication
Male
Opiate Substitution Treatment
/ methods
Opioid-Related Disorders
/ drug therapy
Pain
/ drug therapy
Pain Management
/ methods
Pain, Postoperative
/ prevention & control
Perioperative Care
/ methods
Receptors, Opioid, mu
/ drug effects
Analgesia
Buprenorphine
Opioid-related disorders
Pain
Partial opioid agonists
Postoperative
Journal
The Medical clinics of North America
ISSN: 1557-9859
Titre abrégé: Med Clin North Am
Pays: United States
ID NLM: 2985236R
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
entrez:
26
11
2021
pubmed:
27
11
2021
medline:
15
12
2021
Statut:
ppublish
Résumé
Buprenorphine formulations (including buprenorphine/naloxone) are effective treatments of pain and opioid use disorder (OUD). Historically, perioperative management of patients prescribed buprenorphine involved abstinence from buprenorphine sufficient to allow for unrestricted mu-opioid receptor availability to full agonist opioid (FAO) treatment. Evidence is mounting that a multimodal analgesic strategy, including simultaneous administration of buprenorphine and FAO, nonopioid adjuncts such as acetaminophen and nonsteroidal anti-inflammatory drugs, and regional anesthesia, is a safe and effective perioperative strategy for the patient prescribed long-term buprenorphine treatment of OUD. This strategy will likely simplify management and more seamlessly provide continuous buprenorphine treatment of OUD after hospital discharge.
Identifiants
pubmed: 34823729
pii: S0025-7125(21)00121-8
doi: 10.1016/j.mcna.2021.09.001
pii:
doi:
Substances chimiques
Analgesics, Non-Narcotic
0
Analgesics, Opioid
0
Anti-Inflammatory Agents, Non-Steroidal
0
Receptors, Opioid, mu
0
Acetaminophen
362O9ITL9D
Buprenorphine
40D3SCR4GZ
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
169-185Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure Dr M.B. Weimer discloses an advisory role with Path CCM, Inc. The other authors have nothing to disclose. The views and opinions of authors expressed herein do not necessarily state or reflect those of the US government or any agency thereof.